Amundi Alnylam Pharmaceuticals, Inc. Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Amundi holds 593,320 shares of ALNY stock, worth $146 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

593,320

Previous 737,290 19.53%

Holding current value

$146 Million

Previous $179 Million 8.9%

% of portfolio

0.06%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $33.7 Million - $41.3 Million	-143,970 Reduced 19.53%	593,320 $163 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $1.26 Million - $2.17 Million	-8,774 Reduced 1.18%	737,290 $179 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $5.04 Million - $6.81 Million	34,372 Added 4.83%	746,064 $111 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $14.7 Million - $19.1 Million	97,333 Added 15.84%	711,692 $136 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $10.3 Million - $12.8 Million	-60,409 Reduced 8.95%	614,359 $109 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $3.88 Million - $4.45 Million	20,988 Added 3.21%	674,768 $128 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $2.51 Million - $3.24 Million	-13,753 Reduced 2.06%	653,780 $131 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $98 Million - $128 Million	-528,376 Reduced 44.18%	667,533 $159 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $40.1 Million - $67.1 Million	289,375 Added 31.92%	1,195,909 $240 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $3.8 Million - $5.35 Million	31,584 Added 3.61%	906,534 $126 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $78.9 Million - $108 Million	620,695 Added 244.12%	874,950 $142 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $975,549 - $1.28 Million	-6,114 Reduced 2.35%	254,255 $37.6 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $7.82 Million - $9.57 Million	46,060 Added 21.49%	260,369 $49.2 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $27.6 Million - $37.9 Million	214,309 New	214,309 $36.3 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account